AptarGroup, Inc. (ATR)
NYSE: ATR · Real-Time Price · USD
124.71
-0.40 (-0.32%)
Jan 16, 2026, 4:00 PM EST - Market closed
AptarGroup Employees
AptarGroup had 13,500 employees as of December 31, 2024. The number of employees decreased by 300 or -2.17% compared to the previous year.
Employees
13,500
Change (1Y)
-300
Growth (1Y)
-2.17%
Revenue / Employee
$271,299
Profits / Employee
$31,066
Market Cap
8.18B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 13,500 | -300 | -2.17% |
| Dec 31, 2023 | 13,800 | 300 | 2.22% |
| Dec 31, 2022 | 13,500 | 500 | 3.85% |
| Dec 31, 2021 | 13,000 | 0 | - |
| Dec 31, 2020 | 13,000 | -1,000 | -7.14% |
| Dec 31, 2019 | 14,000 | -100 | -0.71% |
| Dec 31, 2018 | 14,100 | 900 | 6.82% |
| Dec 31, 2017 | 13,200 | 500 | 3.94% |
| Dec 31, 2016 | 12,700 | -300 | -2.31% |
| Dec 31, 2015 | 13,000 | 0 | - |
| Dec 31, 2014 | 13,000 | 600 | 4.84% |
| Dec 31, 2013 | 12,400 | 400 | 3.33% |
| Dec 31, 2012 | 12,000 | 1,100 | 10.09% |
| Dec 31, 2011 | 10,900 | 2,300 | 26.74% |
| Dec 31, 2010 | 8,600 | -100 | -1.15% |
| Dec 31, 2009 | 8,700 | 0 | - |
| Dec 31, 2008 | 8,700 | 300 | 3.57% |
| Dec 31, 2007 | 8,400 | 200 | 2.44% |
| Dec 31, 2006 | 8,200 | 1,000 | 13.89% |
| Dec 31, 2005 | 7,200 | 400 | 5.88% |
| Dec 31, 2004 | 6,800 | 200 | 3.03% |
| Dec 31, 2003 | 6,600 | -100 | -1.49% |
| Dec 31, 2002 | 6,700 | 100 | 1.52% |
| Dec 31, 2001 | 6,600 | 200 | 3.13% |
| Dec 31, 2000 | 6,400 | 200 | 3.23% |
| Dec 31, 1999 | 6,200 | 500 | 8.77% |
| Dec 31, 1998 | 5,700 | 1,600 | 39.02% |
| Dec 31, 1997 | 4,100 | 200 | 5.13% |
| Dec 31, 1996 | 3,900 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ATR News
- 4 days ago - AptarGroup, Inc. (ATR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 11 days ago - Aptar Announces 2026 Quarterly Conference Call Dates - Business Wire
- 13 days ago - Aptar to Present at 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026 - Business Wire
- 4 weeks ago - Aptar's Bidose Nasal System Delivers CARDAMYST™ (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT) - Business Wire
- 6 weeks ago - Aptar Named One of America's Most Responsible Companies by Newsweek for the Seventh Consecutive Year - Business Wire
- 6 weeks ago - Aptar Strengthens Latin America Footprint With Sommaplast Buy - Benzinga
- 7 weeks ago - Touchstone Mid Cap Fund Q3 2025 Portfolio Review - Seeking Alpha
- 2 months ago - AptarGroup, Inc. (ATR) Presents at Jefferies London Healthcare Conference 2025 Transcript - Seeking Alpha